About Index Trending news
Top 50 Pricing


Work at Abingworth? Add yourself to this profile


Abingworth is an international investment group collaborating with life sciences entrepreneurs to develop products that have a dramatic impact on health.


Alexa global traffic share

Twitter followers

22.0M USD Series B in Oct, 2013
70.0M USD Series E in Feb, 2015
150.0M USD Series C in Sep, 2011
5.3M USD Series D in Jan, 2013
45.0M USD Series D in May, 2014
145.0M USD Private equity in May, 2009
12.0M USD Venture capital in May, 2011
60.0M USD Series C in Jul, 2013
65.0M USD Series C in Mar, 2012
60.1M USD Series C in Jun, 2009
36.0M USD Series B in Oct, 2009
45.0M USD Venture capital in May, 2013
20.0M USD Series C in Oct, 2009
30.0M USD Series C in Oct, 2010
29.0M USD Series B in Jan, 2009
Exit: Biotie Therapies for $121.5M on Jan 11, 2011
19.3M USD Series A in Nov, 2013
64.0M USD Series B in Apr, 2015
22.0M USD Series A in Jul, 2015
43.0M USD Series B in Mar, 2016
27.0M USD Series A in Jun, 2016

Want to see the complete list?
Go Pro!